Kasper Roet Email

Founder and CEO QurAlis . QurAlis

Current Roles

Employees:
101
Revenue:
$15.7M
About
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
QurAlis Address
100 Cambridgepark Drive
Cambridge, MA
United States
QurAlis Email

Past Companies

QurAlisFounder and CEO of QurAlis
EnClear TherapiesBoard member and Scientific Advisory Board member
Harvard Medical School/ Boston Children's Hospital/ Harvard UniversityFellow

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.